Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs
Health
By Dani Blum and Rebecca Robbins from NYT Health https://ift.tt/1vWdGla
via IFTTT Diet and Nutrition, United States Politics and Government, Weight, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, GLP-1 RAs (Drug), Regulation and Deregulation of Industry, Diabetes, Ozempic (Drug), Medicare The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.

By Dani Blum and Rebecca Robbins from NYT Health https://ift.tt/1vWdGla
via IFTTT Diet and Nutrition, United States Politics and Government, Weight, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, GLP-1 RAs (Drug), Regulation and Deregulation of Industry, Diabetes, Ozempic (Drug), Medicare The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.
Comments
Post a Comment